General Surgery Coding Alert - 2005 Issue 39
ENFORCEMENT WATCH: DOJ Chips Away At 'Double Dipping' Schemes
Subscribe or sign in to view the full article.
Article Overview
This article covers a Department of Justice enforcement action involving alleged drug pricing inflation, reimbursement impacts on federal healthcare programs, and a related whistleblower-driven settlement. It is relevant to providers, compliance teams, billing professionals, and anyone tracking fraud-and-abuse oversight in Medicare and Medicaid reimbursement. The piece also notes an integrity agreement update and the broader focus on accurate pricing data used by federal programs.
Why This Topic Matters
The article highlights how pricing accuracy can affect reimbursement and trigger fraud investigations, settlements, and compliance obligations in federal healthcare programs.
What You Will Learn
- How drug pricing allegations can affect federal reimbursement
- How a whistleblower action can lead to a DOJ investigation and settlement
- How compliance requirements may be reinforced through integrity agreement updates
- What kinds of Medicare and Medicaid oversight issues are being emphasized in enforcement actions
Who Should Read This
- Medical coders
- Billing staff
- Compliance officers
- Revenue cycle professionals
- Healthcare administrators
- Pharmacy billing teams
Subscribe or sign in to view the full article.
Quick, Current, Complete - www.findacode.com